Zacks Investment Research on MSN
MNMD stock up more than 100% in 6 months: What's in store for 2026?
MNMD is developing its lead pipeline candidate MM120, an orally disintegrating tablet (ODT) and a pharmaceutically optimized form of lysergide D-tartrate, for the treatment of generalized anxiety ...
Zacks Investment Research on MSN
Ocugen stock surges 75% year to date: What's in store for 2026?
Ocugen OCGN is making rapid progress in its gene therapy programs for retinal diseases, which have differentiated mechanisms ...
For some American enthusiasts, 2026 can be a year to remember because it brings the possibility of importing these impressive ...
Modeled on a pair of 1957 watches, Vacheron Constantin’s latest 42.5mm Patrimony Moon Phase Retrograde Date ($58,000 in pink ...
MARION, Ill. — One of three developers entrusted by state and city of Marion officials to oversee a multimillion ...
Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...
Lada Gardens in Dededo will get 16 more low-income rental units renovated, Adelup said on Monday. A groundbreaking was held ...
NDA supported by results from a Phase II registration trial in China - - Second most common form of liver cancer after hepatocellular carcinoma, with generally poorer long-term survival in comparison ...
As GCCs evolve into global innovation and decision-making hubs, flexible and managed workspaces are becoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results